Terumo BCT receives FDA approval to evaluate cell collection protocol

Terumo BCT receives FDA approval to evaluate cell collection protocol

LAKEWOOD - Terumo BCT , a leader in blood component, therapeutic apheresis and cellular technologies, has received approval from the U.S. Food and Drug Administration to conduct a controlled... Read More

By: Steve Monday January 7, 2013 0 comments Tags: Bob Sullivan, Lakewood, Spectra Optia, Terumo BCT, Therapeutic Systems